World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
58
Citations
10502
World Ranking
3551
National Ranking
1642

Overview

Bradley E. Chipps is affiliated with the American College of Allergy, Asthma and Immunology in the United States. Their research primarily focuses on medicine, with extensive work in subfields such as physiology, pulmonary and respiratory medicine, immunology and allergy, surgery, and pediatrics, perinatology, and child health.

The main topics covered in their research include:

  • Asthma and respiratory diseases
  • Respiratory and cough-related research
  • Inhalation and respiratory drug delivery
  • Chronic obstructive pulmonary disease (COPD) research
  • Allergic rhinitis and sensitization
  • Eosinophilic esophagitis
  • Pharmaceutical studies and practices

Bradley E. Chipps has published frequently in several key venues:

  • Annals of Allergy Asthma & Immunology (48 publications)
  • Journal of Allergy and Clinical Immunology (31 publications)
  • The Journal of Allergy and Clinical Immunology In Practice (21 publications)
  • CHEST Journal (6 publications)
  • Journal of Asthma and Allergy (6 publications)

Their recent papers include:

  • "T2-'Low' Asthma: Overview and Management Strategies", 2020, The Journal of Allergy and Clinical Immunology In Practice
  • "Albuterol-Budesonide Fixed-Dose Combination Rescue Inhaler for Asthma", 2022, New England Journal of Medicine
  • "Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment", 2023, Annals of Allergy Asthma & Immunology
  • "Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis", 2020, Annals of Allergy Asthma & Immunology
  • "Development of the Asthma Impairment and Risk Questionnaire (AIRQ): A Composite Control Measure", 2020, The Journal of Allergy and Clinical Immunology In Practice

Frequent co-authors collaborating with Bradley E. Chipps include:

  • Reynold A. Panettieri
  • Ileen Gilbert
  • Alberto Papi
  • Robert S. Zeiger
  • James M. Eudicone

Best Publications

  • Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma

    Chantal M. Dolan;Kyle E. Fraher;Eugene R. Bleecker;Larry Borish

  • Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study

    Thomas B. Casale;Allan T. Luskin;William Busse;Robert S. Zeiger

  • Phenotypes determined by cluster analysis in severe or difficult-to-treat asthma

    Michael Schatz;Jin-Wen Y. Hsu;Robert S. Zeiger;Wansu Chen

  • Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study

    Bradley E. Chipps;Robert S. Zeiger;Larry Borish;Sally E. Wenzel

  • Extent, patterns, and burden of uncontrolled disease in severe or difficult-to-treat asthma

    S D Sullivan;L Rasouliyan;P A Russo;T Kamath

  • Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study.

    June H. Lee;Tmirah Haselkorn;Larry Borish;Lawrence Rasouliyan

  • A randomized multicenter study evaluating Xolair persistence of response after long-term therapy.

    Dennis Ledford;William Busse;Benjamin Trzaskoma;Theodore A. Omachi

  • Allergy testing in childhood: Using allergen-specific IgE tests

    Scott H. Sicherer;Robert A. Wood;Stuart Abramson;Bradley E. Chipps

  • Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study.

    Tmirah Haselkorn;James E. Fish;Robert S. Zeiger;Stanley J. Szefler

  • Total serum IgE levels in a large cohort of patients with severe or difficult-to-treat asthma

    Larry Borish;Bradley Chipps;Yamo Deniz;Sheila Gujrathi

  • Dupilumab Efficacy in Patients with Uncontrolled, Moderate-to-Severe Allergic Asthma.

    Jonathan Corren;Mario Castro;Thomas O'Riordan;Nicola A. Hanania

  • Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma.

    Thomas B. Casale;Bradley E. Chipps;Karin Rosén;Benjamin Trzaskoma

  • The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

    Kenneth R. Chapman;Frank C. Albers;Bradley Chipps;Xavier Muñoz

  • Test for Respiratory and Asthma Control in Kids (TRACK) : A caregiver-completed questionnaire for preschool-aged children

    Kevin R. Murphy;Robert S. Zeiger;Mark Kosinski;Bradley Chipps

  • Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience.

    Bradley E. Chipps;Bob Lanier;Henry Milgrom;Antoine Deschildre

  • Section on allergy and immunology

    Stuart L. Abramson;James R. Banks;Arnold;Theresa A. Bingemann

  • Overlap of atopic, eosinophilic, and TH2-high asthma phenotypes in a general population with current asthma

    Trung N. Tran;Robert S. Zeiger;Stephen P. Peters;Gene Colice

  • Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthma

    Tmirah Haselkorn;Robert S. Zeiger;Bradley E. Chipps;David R. Mink

  • Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma.

    Allan T. Luskin;Bradley E. Chipps;Lawrence Rasouliyan;Dave P. Miller

  • The Childhood Asthma Control Test∗: Retrospective determination and clinical validation of a cut point to identify children with very poorly controlled asthma

    Andrew H. Liu;Robert S. Zeiger;Christine A. Sorkness;Nancy K. Ostrom

  • T2-"Low" Asthma: Overview and Management Strategies.

    Anne M. Fitzpatrick;Bradley E. Chipps;Fernando Holguin;Prescott G. Woodruff

  • Economic burden of impairment in children with severe or difficult-to-treat asthma

    Stanley J. Szefler;Robert S. Zeiger;Tmirah Haselkorn;David R. Mink

Frequent Co-Authors

Robert S. Zeiger
Robert S. Zeiger Kaiser Permanente
Stanley J. Szefler
Stanley J. Szefler University of Colorado Denver
Reynold A. Panettieri
Reynold A. Panettieri Rutgers, The State University of New Jersey
Thomas B. Casale
Thomas B. Casale University of South Florida
Donald P. Tashkin
Donald P. Tashkin University of California, Los Angeles
Wendy C. Moore
Wendy C. Moore Wake Forest University
William W. Busse
William W. Busse University of Wisconsin–Madison
Eugene R. Bleecker
Eugene R. Bleecker University of Arizona
Nicola A. Hanania
Nicola A. Hanania Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, pursuing related healthcare degrees online can open diverse career opportunities. Those aiming to specialize in mental health may consider exploring the cheapest psych np programs online, which offer affordable pathways to become psychiatric nurse practitioners.

Advanced nursing roles such as Doctor of Nursing Practice (DNP) can be highly rewarding, with compensation varying by location. To understand potential earnings, it's helpful to review data on how much do dnps make, helping students plan their educational investment accordingly.

Nurses looking to expand their expertise might explore transitioning from family-focused practice to more specialized care. Resources on fnp to acnp transitions provide valuable guidance for those interested in acute care roles.

For those ready to accelerate their education, programs like the accelerated fnp program offer streamlined online pathways to become family nurse practitioners, combining flexibility with rigorous training.

Best Scientists Citing Bradley E. Chipps

Trending Scientists